What We’re Reading: Social Media Regulations; Merck’s Antibody-Based RSV Vaccine; Drug Shortages Continue
RSV Testing Among Infants With Bronchiolitis Is Increasing, Study Shows
Nirsevimab Reduces Risk of RSV-Associated Bronchiolitis, Study Finds
Nonadjuvanted Bivalent RSV Vaccination Not Associated With Preterm Birth, Study Finds
Which Demographic, Environmental Factors Have Higher Risks for RSV Hospitalization?
Addressing Vaccine Fatigue
The Potential Benefits of RSV Vaccine Approval for Adults Aged 50-59
Financial and Clinical Benefits of RSV Immunization
Shared Decision-Making Practices in RSV
Increasing Awareness of RSV Vaccines in At-Risk Patients
Diagnostic Practices for RSV
RSV: Risk Factors and How It’s Spread
The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV
Complications Associated with RSV Infections
Overview of RSV Patient Populations
Most US Infants With RSV Were Healthy, Born at Term, Study Finds